AstraZeneca Named In Stock-Drop Suit Over COVID-19 Vaccine Misrepresentations

(January 28, 2021, 1:13 PM EST) -- NEW YORK — An investor sued biopharmaceutical company AstraZeneca PLC and certain of its senior executives in New York federal court on Jan. 26, alleging that the defendants misrepresented the success...
To view the full article, register now.